tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

QuidelOrtho sees FY25 COVID-19 revenue $70M-$100M

Says COVID revenue guidance assumes no government contract revenue. Says Labs business growth expected in mid-single digits in FY25. Sees FY25 gross tariff impacts of $20M-$25M to be fully mitigated through cost actions. Says achieved $100M annualized cost-savings initiatives. Guidance taken from Q2 earnings conference call presentation slides.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1